Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2008 1
2009 3
2010 3
2011 3
2012 1
2014 1
2017 1
2018 1
2019 2
2020 5
2021 6
2022 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWH.
Vergori A, Cozzi-Lepri A, Matusali G, Colavita F, Cicalini S, Gallì P, Garbuglia AR, Fusto M, Puro V, Maggi F, Girardi E, Vaia F, Antinori A; HIV-VAC Study Group. Vergori A, et al. Among authors: galli p. Viruses. 2022 Aug 3;14(8):1710. doi: 10.3390/v14081710. Viruses. 2022. PMID: 36016332 Free PMC article.
UV-C irradiation is highly effective in inactivating SARS-CoV-2 replication.
Biasin M, Bianco A, Pareschi G, Cavalleri A, Cavatorta C, Fenizia C, Galli P, Lessio L, Lualdi M, Tombetti E, Ambrosi A, Redaelli EMA, Saulle I, Trabattoni D, Zanutta A, Clerici M. Biasin M, et al. Among authors: galli p. Sci Rep. 2021 Mar 18;11(1):6260. doi: 10.1038/s41598-021-85425-w. Sci Rep. 2021. PMID: 33737536 Free PMC article.
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV.
Vergori A, Cozzi Lepri A, Cicalini S, Matusali G, Bordoni V, Lanini S, Meschi S, Iannazzo R, Mazzotta V, Colavita F, Mastrorosa I, Cimini E, Mariotti D, De Pascale L, Marani A, Gallì P, Garbuglia A, Castilletti C, Puro V, Agrati C, Girardi E, Vaia F, Antinori A; HIV-VAC study group. Vergori A, et al. Among authors: galli p. Nat Commun. 2022 Aug 22;13(1):4922. doi: 10.1038/s41467-022-32263-7. Nat Commun. 2022. PMID: 35995780 Free PMC article.
Evaluation of efficacy and tolerability of first-line therapies in NMOSD.
Poupart J, Giovannelli J, Deschamps R, Audoin B, Ciron J, Maillart E, Papeix C, Collongues N, Bourre B, Cohen M, Wiertlewski S, Outteryck O, Laplaud D, Vukusic S, Marignier R, Zephir H; NOMADMUS study group. Poupart J, et al. Neurology. 2020 Apr 14;94(15):e1645-e1656. doi: 10.1212/WNL.0000000000009245. Epub 2020 Mar 13. Neurology. 2020. PMID: 32170036
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count.
Antinori A, Cicalini S, Meschi S, Bordoni V, Lorenzini P, Vergori A, Lanini S, De Pascale L, Matusali G, Mariotti D, Cozzi Lepri A, Gallì P, Pinnetti C, Gagliardini R, Mazzotta V, Mastrorosa I, Grisetti S, Colavita F, Cimini E, Grilli E, Bellagamba R, Lapa D, Sacchi A, Marani A, Cerini C, Candela C, Fusto M, Puro V, Castilletti C, Agrati C, Girardi E, Vaia F; HIV-VAC Study Group. Antinori A, et al. Among authors: galli p. Clin Infect Dis. 2022 Aug 24;75(1):e552-e563. doi: 10.1093/cid/ciac238. Clin Infect Dis. 2022. PMID: 35366316 Free PMC article.
Oxaliplatin-induced proximal renal tubular acidosis.
Negro A, Grasselli C, Galli P. Negro A, et al. Among authors: galli p. Intern Emerg Med. 2010 Jun;5(3):267-8. doi: 10.1007/s11739-009-0331-7. Epub 2009 Nov 25. Intern Emerg Med. 2010. PMID: 19937480 No abstract available.
34 results